Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer

NCT00363285 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

900

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

BIOLOGICAL: gonadotrophin releasing hormone
DRUG: cyproterone acetate
PROCEDURE: quality-of-life assessment

Sponsor

St. Bartholomew's Hospital